Incyte expands in Scandinavia and plans to more than double its employees

With several scheduled launches, Incyte Biosciences is in a hurry to expand the organization's local departments. This is also the case in the Nordics, where the General Manager Erik Fromm expects to double the firm's employees.

Photo: Incyte / PR

The US biotech firm Incyte is still in the process of setting up shop in Denmark and the Nordics, but it plans to grow in the coming years. The company is already growing in size both in and outside of the US, according to Incyte's General Manager Erik Fromm, who currently leads 12 employees across the Nordics.

"If all of Incyte's plans relating to new approvals and clinical studies run as planned, the idea is for us to be twice as many employees in the Nordic unit in the foreseeable future both in terms of commercial functions and research and development," he tells MedWatch.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs